S 1302
17 links on this map: who funds them, what they touched, and who lobbied on it. Select anyone to move the map to them.
Start with
and connect to
Gave to its sponsors8 of 30
Barbara J. Couch$22KWilliam T. Korn$18KPerry Browder$17KRobert Katz$17KNicholas Kukrika$17KRobert McNeal$17KStacy Schusterman$17KOlivia Sears$17KSponsors6 cosponsors more
Margaret HassanCongress · New Hampshire · DS 1302
Increasing Transparency in Generic Drug Applications Act
Congress · In committee
Lobbied on it8 of 17
Viatris Inc14 reportsAssociation for Accessible Medicines10 reportsWashington Strategic Consulting8 reportsBcbsm Inc6 reportsBlue Cross and Blue Shield Association6 reportsBlue Cross and Blue Shield of Florida Inc6 reportsBlue Cross Blue Shield of Michigan6 reportsGSK (Fka Glaxosmithkline Inc.)6 reportsEvery link on this map
The same connections as a table, with the reason each one is here.
| Barbara J. Couch | Gave to its sponsors | Barbara J. Couch gave $22K to a sponsor of S 1302. A gift is not a position on the bill. | $22K |
| William T. Korn | Gave to its sponsors | William T. Korn gave $18K to a sponsor of S 1302. A gift is not a position on the bill. | $18K |
| Perry Browder | Gave to its sponsors | Perry Browder gave $17K to a sponsor of S 1302. A gift is not a position on the bill. | $17K |
| Robert Katz | Gave to its sponsors | Robert Katz gave $17K to a sponsor of S 1302. A gift is not a position on the bill. | $17K |
| Nicholas Kukrika | Gave to its sponsors | Nicholas Kukrika gave $17K to a sponsor of S 1302. A gift is not a position on the bill. | $17K |
| Robert McNeal | Gave to its sponsors | Robert McNeal gave $17K to a sponsor of S 1302. A gift is not a position on the bill. | $17K |
| Stacy Schusterman | Gave to its sponsors | Stacy Schusterman gave $17K to a sponsor of S 1302. A gift is not a position on the bill. | $17K |
| Olivia Sears | Gave to its sponsors | Olivia Sears gave $17K to a sponsor of S 1302. A gift is not a position on the bill. | $17K |
| Margaret Hassan | Sponsors | Margaret Hassan sponsored S 1302. | None |
| Viatris Inc | Lobbied on it | Viatris Inc named S 1302 in 14 lobbying reports. | 14 reports |
| Association for Accessible Medicines | Lobbied on it | Association for Accessible Medicines named S 1302 in 10 lobbying reports. | 10 reports |
| Washington Strategic Consulting | Lobbied on it | Washington Strategic Consulting named S 1302 in 8 lobbying reports. | 8 reports |
| Bcbsm Inc | Lobbied on it | Bcbsm Inc named S 1302 in 6 lobbying reports. | 6 reports |
| Blue Cross and Blue Shield Association | Lobbied on it | Blue Cross and Blue Shield Association named S 1302 in 6 lobbying reports. | 6 reports |
| Blue Cross and Blue Shield of Florida Inc | Lobbied on it | Blue Cross and Blue Shield of Florida Inc named S 1302 in 6 lobbying reports. | 6 reports |
| Blue Cross Blue Shield of Michigan | Lobbied on it | Blue Cross Blue Shield of Michigan named S 1302 in 6 lobbying reports. | 6 reports |
| GSK (Fka Glaxosmithkline Inc.) | Lobbied on it | GSK (Fka Glaxosmithkline Inc.) named S 1302 in 6 lobbying reports. | 6 reports |